117 related articles for article (PubMed ID: 26265235)
1. Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.
Parham LR; Briley LP; King KS; Byrne J; Rappold E; Goss PE; Spraggs CF
Pharmacogenomics; 2015; 16(11):1227-9. PubMed ID: 26265235
[TBL] [Abstract][Full Text] [Related]
2. Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury.
Schaid DJ; Spraggs CF; McDonnell SK; Parham LR; Cox CJ; Ejlertsen B; Finkelstein DM; Rappold E; Curran J; Cardon LR; Goss PE
J Clin Oncol; 2014 Aug; 32(22):2296-303. PubMed ID: 24687830
[TBL] [Abstract][Full Text] [Related]
3. HLA polymorphisms influence the development of skin rash arising from treatment with EGF receptor inhibitors.
Fuerst D; Parmar S; Schumann C; Rüdiger S; Boeck S; Heinemann V; Kaechele V; Stiebel K; Paul T; Seufferlein T; Mytilineos J; Stingl JC
Pharmacogenomics; 2012 Oct; 13(13):1469-76. PubMed ID: 23057547
[TBL] [Abstract][Full Text] [Related]
4. Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.
Parma J; Pavlick A; Schiff R; Osborne CK; Chang JC; Rimawi M; Trivedi MV
Pharmacotherapy; 2013 Oct; 33(10):1126-9. PubMed ID: 23744830
[TBL] [Abstract][Full Text] [Related]
5. [Possible association between polymorphisms of human leukocyte antigen-DQ genes and susceptibility to trichloroethylene-induced severe generalized dermatitis].
Li HS; Dai YF; Huang HL; Feng XL; Sun YF; Niu Y; Cheng J; Zhang LY; Li LY; Chen B; Zheng YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 May; 40(3):173-6. PubMed ID: 16836882
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01.
Parham LR; Briley LP; Li L; Shen J; Newcombe PJ; King KS; Slater AJ; Dilthey A; Iqbal Z; McVean G; Cox CJ; Nelson MR; Spraggs CF
Pharmacogenomics J; 2016 Apr; 16(2):180-5. PubMed ID: 25987243
[TBL] [Abstract][Full Text] [Related]
7. Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis.
Liu HY; Deng AM; Zhou Y; Yao DK; Xu DX; Zhong RQ
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):129-32. PubMed ID: 16481299
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
9. Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope.
Malysheva O; Pierer M; Wagner U; Wahle M; Wagner U; Baerwald CG
Ann Rheum Dis; 2008 Dec; 67(12):1759-64. PubMed ID: 18267980
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanes.
Spraggs CF; Parham LR; Briley LP; Warren L; Williams LS; Fraser DJ; Jiang Z; Aziz Z; Ahmed S; Demetriou G; Mehta A; Jackson N; Byrne J; Andersson M; Toi M; Harris L; Gralow J; Zujewski JA; Crescenzo R; Armour A; Perez E; Piccart M
Pharmacogenomics J; 2018 May; 18(3):480-486. PubMed ID: 28786423
[TBL] [Abstract][Full Text] [Related]
11. Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms.
Kulkarni D; Song K; Briley L; King K; Dabrowski C; Mookerjee B; Legos J; Spraggs C
Pharmacogenomics; 2016 Apr; 17(5):459-62. PubMed ID: 27023328
[TBL] [Abstract][Full Text] [Related]
12. [Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study].
Mushiroda T
Rinsho Byori; 2014 Jan; 62(1):83-8. PubMed ID: 24724431
[TBL] [Abstract][Full Text] [Related]
13. The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01.
Hirasawa M; Hagihara K; Okudaira N; Izumi T
PLoS One; 2015; 10(6):e0130928. PubMed ID: 26098642
[TBL] [Abstract][Full Text] [Related]
14. The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population.
Moon J; Park HK; Chu K; Sunwoo JS; Byun JI; Lim JA; Kim TJ; Shin JW; Lee ST; Jung KH; Jung KY; Jeon D; Kim DW; Yu KS; Jang IJ; Kang HR; Park HW; Lee SK
Epilepsia; 2015 Oct; 56(10):e161-7. PubMed ID: 26282450
[TBL] [Abstract][Full Text] [Related]
15. HLA allele and haplotype frequencies in the Albanian population and their relationship with the other European populations.
Sulcebe G; Sanchez-Mazas A; Tiercy JM; Shyti E; Mone I; Ylli Z; Kardhashi V
Int J Immunogenet; 2009 Dec; 36(6):337-43. PubMed ID: 19703234
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen alleles in patients with bipolar disorder in the Korean population.
Jun TY; Pae CU; Chae JH; Pyo CW; Han H
Psychiatry Clin Neurosci; 2002 Aug; 56(4):453-7. PubMed ID: 12109964
[TBL] [Abstract][Full Text] [Related]
17. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis.
Maksymowych WP; Suarez-Almazor ME; Buenviaje H; Cooper BL; Degeus C; Thompson M; Russell AS
J Rheumatol; 2002 Nov; 29(11):2319-26. PubMed ID: 12415587
[TBL] [Abstract][Full Text] [Related]
18. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen genotypes and trial of desensitization in patients with oxcarbazepine-induced skin rash: a pilot study.
Lee B; Yu HJ; Kang ES; Lee M; Lee J
Pediatr Neurol; 2014 Aug; 51(2):207-14. PubMed ID: 25079569
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.
Spraggs CF; Budde LR; Briley LP; Bing N; Cox CJ; King KS; Whittaker JC; Mooser VE; Preston AJ; Stein SH; Cardon LR
J Clin Oncol; 2011 Feb; 29(6):667-73. PubMed ID: 21245432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
